Publications of Daniel Rüdiger

Pelz, L.; Rüdiger, D.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Evolution and selection of influenza a virus defective interfering particles in a semi-continuous production system for the use as antiviral. The seventh ESWI Influenza Conference, Virtual Meeting (2020)

Rüdiger, D.; Pelz, L.; Hein, M.; Kupke, S. Y.; Reichl, U.: Multiscale model of DIP replication and its effects on influenza A virus infection in animal cell culture. Society for Mathematical Biology 2020 Annual Meeting, Virtual Meeting (2020)

Rüdiger, D.; Laske, T.; Kupke, S. Y.; Reichl, U.: Multiscale model of DIP interference and production during influenza A virus infection in animal cell culture. 4th Workshop on Virus Dynamics, Paris, France (2019)

Rüdiger, D.; Kupke, S. Y.; Zmora, P.; Reichl, U.: Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditions. 3rd Workshop on Virus Dynamics, Heidelberg, Germany (2017)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M.; Baelkner, M.; Boehme, J.D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y. et al.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Genetically engineered defective interfering particles for antiviral treatment and vaccination. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Pelz, L.; Dogra, T.; Rüdiger, D.; Boehme, J.; Kershaw, O.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 28th ESACT Meeting, Edinburgh (Scotland) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: A two-dimensional model to predict coinfection of influenza A virus with defective interfering particles in tissue-like systems. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 8^th European Congress of Virology, Gdańsk (Poland) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8^th European Congress of Virology, Gdańsk (Poland) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17^th Vaccine Congress, Glasgow (Scotland) (2023)

Dogra, T.; Pelz, L.; Marc, H.; Rüdiger, D.; Boehme, J.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F.G.; Genzel, Y.; Brooke, C.B.; Kupke, S. Y.; Reichl, U.: Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)